ZHIWEI, WEI – Trademark Portfolio

Entity Type: 01

ZHIWEI, WEI holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 24 (Fabrics) — 3 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SELQNQ, KOQDIVA, and PELVXANE. The owner is based in NINGBO, ZHEJIANG.

RM 307, BLDG 19, NO. 33, LANE 37,

HONGTANG, ST., JIANGBEI DIST.

NINGBO, ZHEJIANG , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PELVXANE
PELVXANE
Registered 2025
KOQDIVA
KOQDIVA
Registered 2025
SELQNQ
SELQNQ
Registered 2025
3L-ORZ
3L-ORZ
Cancelled 2018

Trademark Classifications

ZHIWEI, WEI's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

24
Fabrics (3 filings)

Textiles and textile goods; bed covers; table covers

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does ZHIWEI, WEI have?

ZHIWEI, WEI has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.

What trademark classes does ZHIWEI, WEI file in?

ZHIWEI, WEI files trademarks across 2 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 28 (Toys & Sporting Goods). Class 24 covers textiles and textile goods; bed covers; table covers.

What are ZHIWEI, WEI's most well-known trademarks?

ZHIWEI, WEI's registered trademark portfolio includes well-known marks such as SELQNQ, KOQDIVA, and PELVXANE. These are among 3 currently registered trademarks in the portfolio.

What is ZHIWEI, WEI's trademark registration success rate?

ZHIWEI, WEI has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.